Can a biotech or life sciences lab sell or license its data to AI companies?
Yes. Buyers list lab notebooks and experiment records from biotech and life sciences labs with 10 to 1,000 staff, with a published band of $750K to $1M as of November 2026. Data from human subjects needs consent or de-identification, and partner-owned results usually cannot be shared.
What could your company's records earn? Get a range in 30 seconds. Free, no obligation.
Can a biotech lab license its notebooks to AI companies?
Yes. Buyers publish a program for biotech and life sciences labs and list lab notebooks and experiment records as what they want, for labs of 10 to 1,000 staff, with a ceiling in the $750K to $1M band (published buyer listing, read 20 Nov 2026). The staff range covers a 10-person startup and a 1,000-person organization. See the price table by industry.
The value sits in what journals leave out. Published papers report the result that worked. A notebook records the protocol, the setup, the failed runs and the reasoning for the next step. Failed experiments are rare in public data, and an AI model that has never seen one cannot learn from it.
What are lab records worth?
| Item | Figure | Source |
|---|---|---|
| Published price band per lab | $750K to $1M | Published buyer listing, read 20 Nov 2026 |
| Staff band buyers list | 10 to 1,000 | Same listing |
| Records named | Lab notebooks, experiment records | Same listing |
| Consent route for stored research data | Broad consent for storage and secondary research use of identifiable private information or biospecimens | 45 CFR 46.116(d), read 21 Nov 2026 |
Years of notebooks, whether they are electronic, and whether results link to raw instrument files all raise an offer. Estimate yours with the calculator.
Which lab records do buyers want?
- Notebooks: hypotheses, protocols, observations, deviations and conclusions, whether typed or scanned.
- Experiment records: plate layouts, assay readouts, instrument exports, analysis scripts and their output.
- Failed and null results: runs that did not work, with the notes on why.
A notebook entry linked to its raw data file is worth more than either alone. A scanned handwritten page needs transcription before a buyer can use it.
Which systems hold lab records?
Labs keep notebooks in an electronic lab notebook or in paper binders, sample tracking in a laboratory information system, raw output on instrument computers and network drives, and analysis in code repositories and spreadsheets. Instrument data often sits on aging machines with no backup. See preparing company data.
What can a biotech lab not share?
- Human-subject data without consent. The federal rule at 45 CFR 46.116 permits broad consent as an alternative to ordinary informed consent, but only for the storage, maintenance and secondary research use of identifiable private information and identifiable biospecimens (45 CFR 46.116(d), eCFR, read 21 Nov 2026). Whether a use by an AI buyer fits your signed forms is a question for your ethics board. Old consent forms rarely mention AI.
- Identifiable health information. HHS describes two HIPAA routes to de-identify health information, Expert Determination and Safe Harbor, and says the Privacy Rule does not restrict use of data that meets either (HHS, De-identification guidance, read 21 Nov 2026). Clinical trial records from patients need one of these or an authorization. See de-identification.
- Partner and sponsor results. If a pharmaceutical partner funded the study, the agreement may give them the results. Read it.
- Unpublished discoveries. Data that supports a pending patent or an unpublished finding can damage your position if shared too early. Ask counsel about timing.
- Third-party materials. Cell lines, reagents and material-transfer agreements carry terms on use and sharing.
This page is general information, not legal advice.
How should a lab prepare?
Pick one program that is finished, fully owned and free of human-subject data. Digitize notebooks, link each entry to its raw files, and strip names of collaborators if agreements require it. Keep a log of every partner agreement and who owns what. See how AI data buyers check records.
What does a sample record look like?
Three samples of the notebook, experiment and failed-run records this page lists, with no human-subject data included.
- Entry length
- 3 pages, protocol v2.4
- Deviations noted
- 2 deviations from the written protocol
- Conclusion
- Hypothesis supported at 24 hours
- Linked raw file
- Instrument export linked to the entry
- Personal details
- Collaborator names removed; no human-subject data
- Plate layout
- 96-well, 3 replicates per sample
- Assay readout
- Readout file, 4 time points
- Analysis script
- Script version 1.3 with saved output
- Outcome
- Result repeated in a second run
- Personal details
- No patient samples; partner agreement checked
- Run date
- June 2024
- What failed
- Signal below background in 5 of 6 wells
- Notes on why
- Reagent lot suspected, entry written same day
- Next step
- Repeated with new lot, run succeeded
- Personal details
- No human-subject data; collaborator names removed
Illustrative samples: invented values, real record types.
What has company data sold for?
We record 40 public data sales, each with its price, date and source. Search all 40 recorded data sales.
Questions
Are failed experiments really worth sharing?
Public data holds mostly successes, so failed runs fill a gap. Buyers list experiment records, and null results sit inside them.
Can I include patient samples?
Only under a consent or de-identification route that covers this use. Without one, leave them out.
Do I need to publish first?
No rule on this page requires it, but unpublished findings can affect patent strategy. Ask counsel.
Do academic labs qualify?
The listing says biotech and life sciences labs of 10 to 1,000 staff and does not mention universities. Ask the buyer, and check your institution's data policy.
Sources
- Published buyer industry listings, read 20 Nov 2026 (buyers not named by policy).
- eCFR, 45 CFR 46.116, General requirements for informed consent, read 21 Nov 2026: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46/subpart-A/section-46.116
- US Department of Health and Human Services, Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the HIPAA Privacy Rule, read 21 Nov 2026: https://www.hhs.gov/hipaa/for-professionals/special-topics/de-identification/index.html